Novo Nordisk shares drop after poor trial results for new obesity drug

Once-a-week injection achieved weight loss of 23%, which is lower than some existing treatments

capitalindexers
capitalindexers
 Feb 23, 2026  0  1
 Add to Reading List
Novo Nordisk shares drop after poor trial results for new obesity drug
Once-a-week injection achieved weight loss of 23%, which is lower than some existing treatments
Read More   

Share

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0